Skip to main content
. 2022 Apr 1;17(17):e1445–e1454. doi: 10.4244/EIJ-D-21-00444

Figure 3. Kaplan-Meier estimates of freedom from composite safety endpoint (A), freedom from MAE (B), and freedom from all-cause death (C) up to nine months in the IN.PACT BTK randomised study.

Figure 3

DCB: drug-coated balloon; MAE: major adverse events; PTA: percutaneous transluminal angioplasty